CVS Health Corporation $CVS Shares Acquired by Legal & General Group Plc

Legal & General Group Plc grew its position in shares of CVS Health Corporation (NYSE:CVS) by 3.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,277,933 shares of the pharmacy operator’s stock after purchasing an additional 294,891 shares during the quarter. Legal & General Group Plc’s holdings in CVS Health were worth $699,463,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. SOA Wealth Advisors LLC. increased its holdings in CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares in the last quarter. Alteri Wealth LLC increased its stake in shares of CVS Health by 3.2% in the 3rd quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator’s stock valued at $316,000 after purchasing an additional 131 shares in the last quarter. Holistic Financial Partners boosted its position in CVS Health by 4.1% during the third quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator’s stock worth $256,000 after purchasing an additional 133 shares in the last quarter. Symmetry Partners LLC grew its holdings in CVS Health by 2.5% in the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares during the period. Finally, Harbor Capital Advisors Inc. raised its stake in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on CVS. Leerink Partners reissued an “outperform” rating and issued a $98.00 price target on shares of CVS Health in a report on Thursday, March 5th. TD Cowen boosted their target price on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Wells Fargo & Company cut their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Finally, Barclays increased their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Stock Performance

NYSE CVS opened at $76.15 on Wednesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The stock’s fifty day moving average is $78.39 and its two-hundred day moving average is $77.73. The firm has a market capitalization of $96.87 billion, a P/E ratio of 55.18, a price-to-earnings-growth ratio of 0.82 and a beta of 0.49. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.